Recent Finacing
Recent Raise
Biosplice is a clinical-stage biotechnology company developing small-molecule therapeutics that modulate alternative pre-mRNA splicing via CLK/DYRK kinase and Wnt pathway mechanisms, advancing osteoarthritis, oncology, and neurology programs.
Focus Areas
Recent Investors
Valuation as of 08/06/2018
Total Raised
Funding rounds
Investors
